Dianthus Therapeutics Stock Forward View - Relative Strength Index
| DNTH Stock | 53.39 0.03 0.06% |
Dianthus Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of Dianthus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of Dianthus Therapeutics' stock price is under 68 suggesting that the stock is rather overbought by investors as of 1st of February 2026. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Dianthus, making its price go up or down. Momentum 68
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.86) | EPS Estimate Current Year (3.73) | EPS Estimate Next Year (3.87) | Wall Street Target Price 70.8182 | EPS Estimate Current Quarter (0.90) |
Using Dianthus Therapeutics hype-based prediction, you can estimate the value of Dianthus Therapeutics from the perspective of Dianthus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Dianthus Therapeutics using Dianthus Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Dianthus using crowd psychology based on the activity and movement of Dianthus Therapeutics' stock price.
Dianthus Therapeutics Short Interest
A significant increase or decrease in Dianthus Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Dianthus. Short interest can provide insight into the potential direction of Dianthus Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 30.0873 | Short Percent 0.1994 | Short Ratio 9.19 | Shares Short Prior Month 6.1 M | 50 Day MA 43.605 |
Dianthus Relative Strength Index
Dianthus Therapeutics Hype to Price Pattern
Investor biases related to Dianthus Therapeutics' public news can be used to forecast risks associated with an investment in Dianthus. The trend in average sentiment can be used to explain how an investor holding Dianthus can time the market purely based on public headlines and social activities around Dianthus Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Dianthus Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Dianthus Therapeutics.
Dianthus Therapeutics Implied Volatility | 1.07 |
Dianthus Therapeutics' implied volatility exposes the market's sentiment of Dianthus Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Dianthus Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Dianthus Therapeutics stock will not fluctuate a lot when Dianthus Therapeutics' options are near their expiration.
Dianthus Therapeutics after-hype prediction price | USD 52.23 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Dianthus Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Dianthus contract
Based on the Rule 16, the options market is currently suggesting that Dianthus Therapeutics will have an average daily up or down price movement of about 0.0669% per day over the life of the 2026-03-20 option contract. With Dianthus Therapeutics trading at USD 53.39, that is roughly USD 0.0357 . If you think that the market is fully incorporating Dianthus Therapeutics' daily price movement you should consider acquiring Dianthus Therapeutics options at the current volatility level of 1.07%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Dianthus Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Dianthus Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Dianthus Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Dianthus Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Dianthus Therapeutics' open interest, investors have to compare it to Dianthus Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Dianthus Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Dianthus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Dianthus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dianthus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dianthus using various technical indicators. When you analyze Dianthus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 68.36 | 68.36 |
| Check Dianthus Therapeutics Volatility | Backtest Dianthus Therapeutics | Information Ratio |
Dianthus Therapeutics Trading Date Momentum
| On February 01 2026 Dianthus Therapeutics was traded for 53.39 at the closing time. The top price for the day was 57.50 and the lowest listed price was 52.81 . There was no trading activity during the period 0.0. Lack of trading volume on February 1, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.06% . |
| Compare Dianthus Therapeutics to competition |
Other Forecasting Options for Dianthus Therapeutics
For every potential investor in Dianthus, whether a beginner or expert, Dianthus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dianthus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dianthus. Basic forecasting techniques help filter out the noise by identifying Dianthus Therapeutics' price trends.Dianthus Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dianthus Therapeutics stock to make a market-neutral strategy. Peer analysis of Dianthus Therapeutics could also be used in its relative valuation, which is a method of valuing Dianthus Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dianthus Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dianthus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dianthus Therapeutics shares will generate the highest return on investment. By undertsting and applying Dianthus Therapeutics stock market strength indicators, traders can identify Dianthus Therapeutics entry and exit signals to maximize returns.
Dianthus Therapeutics Risk Indicators
The analysis of Dianthus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dianthus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dianthus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.74 | |||
| Semi Deviation | 2.25 | |||
| Standard Deviation | 4.04 | |||
| Variance | 16.34 | |||
| Downside Variance | 8.23 | |||
| Semi Variance | 5.06 | |||
| Expected Short fall | (3.31) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dianthus Therapeutics
The number of cover stories for Dianthus Therapeutics depends on current market conditions and Dianthus Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dianthus Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dianthus Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Dianthus Therapeutics Short Properties
Dianthus Therapeutics' future price predictability will typically decrease when Dianthus Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dianthus Therapeutics often depends not only on the future outlook of the potential Dianthus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dianthus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.3 M | |
| Cash And Short Term Investments | 275.2 M |
Check out Historical Fundamental Analysis of Dianthus Therapeutics to cross-verify your projections. For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is there potential for Biotechnology market expansion? Will Dianthus introduce new products? Factors like these will boost the valuation of Dianthus Therapeutics. Projected growth potential of Dianthus fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.50) | Revenue Per Share | Quarterly Revenue Growth (0.82) | Return On Assets | Return On Equity |
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Dianthus Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dianthus Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Dianthus Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.